PCSK6 ablation increases atherosclerotic burden, but provides plaque stability by regulating TH17 and smooth muscle cell content

Autor: Matic, L., Suur, B., Karadimou, G., Willems, C., Bergman, O., Lengquist, M., Kronqvist, M., Baumgartner, R., Malin, S., Gisterå, A., Hansson, G., Mälarstig, A., Hedin, U., Ketelhuth, D.
Zdroj: In Atherosclerosis August 2023 379 Supplement 1:S23-S23
Databáze: ScienceDirect